Profile data is unavailable for this security.
About the company
Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.
- Revenue in HKD (TTM)1.44bn
- Net income in HKD97.81m
- Incorporated2001
- Employees1.04k
- LocationLee's Pharmaceutical Holdings LtdUnit 110-111, Bio-Inf. Centre,No.2 Science Park West Avenue,Hong Kong Science Park, Shatin Hong KongHKG
- Phone+852 23141282
- Fax+852 23141708
- Websitehttps://www.leespharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China NT Pharma Group Co Ltd | 21.13m | -80.33m | 505.68m | 21.00 | -- | -- | -- | 23.93 | -0.233 | -0.233 | 0.0488 | -0.4651 | 0.0546 | -- | 3.09 | 960,538.80 | -20.76 | -10.31 | -- | -- | 51.27 | -- | -380.13 | -97.11 | 0.0447 | -0.3973 | 7.95 | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.27bn | 23.28m | 639.06m | 2.49k | 26.82 | 0.5197 | 4.44 | 0.2812 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 882,003.30 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 686.69m | 504.00 | 7.55 | 1.79 | 6.00 | 1.16 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Fusen Pharmaceutical Co Ltd | 272.95m | -198.18m | 687.55m | 1.05k | -- | 1.75 | -- | 2.52 | -0.2681 | -0.2681 | 0.3692 | 0.5309 | 0.1875 | 1.11 | 4.05 | 241,331.70 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Pak Fah Yeow International Ltd | 199.03m | 70.97m | 741.70m | 100.00 | 10.45 | 1.05 | 9.56 | 3.73 | 0.2277 | 0.2277 | 0.6386 | 2.26 | 0.2227 | 1.84 | 24.74 | 1,877,594.00 | 7.94 | 5.03 | 8.68 | 5.24 | 87.44 | 82.23 | 35.66 | 23.92 | 6.21 | 7.72 | 0.0068 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Modern Chinese Medicine Group Co Ltd | 229.01m | 21.49m | 799.20m | 190.00 | 30.98 | 1.21 | 22.94 | 3.49 | 0.0358 | 0.0358 | 0.3817 | 0.9165 | 0.392 | 5.89 | 7.49 | 1,205,326.00 | 3.68 | 14.83 | 3.93 | 17.56 | 24.57 | 38.44 | 9.38 | 17.92 | 7.80 | 21.30 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.44bn | 97.81m | 865.59m | 1.04k | 8.85 | 0.4454 | 4.30 | 0.6026 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 1.01bn | 49.00 | 25.83 | 0.8327 | -- | 26.62 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| 3D Medicines Inc | 507.84m | -190.85m | 1.05bn | 183.00 | -- | 1.30 | -- | 2.07 | -0.779 | -0.779 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,658,870.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Transcenta Holding Ltd | 10.66m | -301.67m | 1.08bn | 171.00 | -- | 1.33 | -- | 101.33 | -0.7445 | -0.7445 | 0.0263 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,909.79 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 207.23m | 1.13bn | 798.00 | 5.46 | 0.5767 | 4.70 | 1.08 | 0.3699 | 0.3699 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,409,174.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
Data as of Feb 16 2026. Currency figures normalised to Lee's Pharmaceutical Holdings Ltd's reporting currency: Hong Kong Dollar HKD
6.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Switzerland AG (Investment Management)as of 14 Oct 2024 | 29.33m | 4.98% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 4.64m | 0.79% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 682.00k | 0.12% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 277.40k | 0.05% |
| DFA Australia Ltd.as of 31 Dec 2025 | 102.94k | 0.02% |
| Lazard Asset Management LLCas of 31 Jan 2026 | 86.11k | 0.02% |
| Acadian Asset Management LLCas of 30 Jun 2025 | 68.17k | 0.01% |
| Carne Global Fund Managers (Ireland) Ltd.as of 31 Mar 2025 | 63.76k | 0.01% |
| FIL Investments Internationalas of 30 Jun 2025 | 50.00k | 0.01% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
